Literature DB >> 30872366

NUTM1 is a recurrent fusion gene partner in B-cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2.

Femke M Hormann1,2, Alex Q Hoogkamer1,2, H Berna Beverloo3, Aurélie Boeree1,2, Ilse Dingjan1,2, Moniek M Wattel3, Ronald W Stam1, Gabriele Escherich4, Rob Pieters1,5, Monique L den Boer1,2,5,6, Judith M Boer7,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30872366      PMCID: PMC6886436          DOI: 10.3324/haematol.2018.206961

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.

Authors:  Nicolas Reynoird; Brian E Schwartz; Manuela Delvecchio; Karin Sadoul; David Meyers; Chandrani Mukherjee; Cécile Caron; Hiroshi Kimura; Sophie Rousseaux; Philip A Cole; Daniel Panne; Christopher A French; Saadi Khochbin
Journal:  EMBO J       Date:  2010-07-30       Impact factor: 11.598

2.  Bmi1 reprograms CML B-lymphoid progenitors to become B-ALL-initiating cells.

Authors:  Amitava Sengupta; Ashley M Ficker; Susan K Dunn; Malav Madhu; Jose A Cancelas
Journal:  Blood       Date:  2011-11-18       Impact factor: 22.113

3.  Long-term maintenance of human hematopoietic stem/progenitor cells by expression of BMI1.

Authors:  Aleksandra Rizo; Bert Dontje; Edo Vellenga; Gerald de Haan; Jan Jacob Schuringa
Journal:  Blood       Date:  2007-12-21       Impact factor: 22.113

4.  Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants.

Authors:  Ronald W Stam; Pauline Schneider; Jill A P Hagelstein; Marieke H van der Linden; Dominique J P M Stumpel; Renee X de Menezes; Paola de Lorenzo; Maria G Valsecchi; Rob Pieters
Journal:  Blood       Date:  2009-12-23       Impact factor: 22.113

5.  Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.

Authors:  Arian van der Veer; Esmé Waanders; Rob Pieters; Marieke E Willemse; Simon V Van Reijmersdal; Lisa J Russell; Christine J Harrison; William E Evans; Vincent H J van der Velden; Peter M Hoogerbrugge; Frank Van Leeuwen; Gabriele Escherich; Martin A Horstmann; Leila Mohammadi Khankahdani; Dimitris Rizopoulos; Hester A De Groot-Kruseman; Edwin Sonneveld; Roland P Kuiper; Monique L Den Boer
Journal:  Blood       Date:  2013-08-23       Impact factor: 22.113

6.  BMI1 enhancer polymorphism underlies chromosome 10p12.31 association with childhood acute lymphoblastic leukemia.

Authors:  Adam J de Smith; Kyle M Walsh; Stephen S Francis; Chenan Zhang; Helen M Hansen; Ivan Smirnov; Libby Morimoto; Todd P Whitehead; Alice Kang; Xiaorong Shao; Lisa F Barcellos; Roberta McKean-Cowdin; Luoping Zhang; Cecilia Fu; Rong Wang; Herbert Yu; Josephine Hoh; Andrew T Dewan; Catherine Metayer; Xiaomei Ma; Joseph L Wiemels
Journal:  Int J Cancer       Date:  2018-10-03       Impact factor: 7.316

7.  DNA methylation-based subtype prediction for pediatric acute lymphoblastic leukemia.

Authors:  Mats G Gustafsson; Gudmar Lönnerholm; Erik Forestier; Ann-Christine Syvänen; Jessica Nordlund; Christofer L Bäcklin; Vasilios Zachariadis; Lucia Cavelier; Johan Dahlberg; Ingegerd Öfverholm; Gisela Barbany; Ann Nordgren; Elin Övernäs; Jonas Abrahamsson; Trond Flaegstad; Mats M Heyman; Ólafur G Jónsson; Jukka Kanerva; Rolf Larsson; Josefine Palle; Kjeld Schmiegelow
Journal:  Clin Epigenetics       Date:  2015-02-17       Impact factor: 6.551

8.  Transcriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profiles.

Authors:  Yanara Marincevic-Zuniga; Johan Dahlberg; Sara Nilsson; Amanda Raine; Sara Nystedt; Carl Mårten Lindqvist; Eva C Berglund; Jonas Abrahamsson; Lucia Cavelier; Erik Forestier; Mats Heyman; Gudmar Lönnerholm; Jessica Nordlund; Ann-Christine Syvänen
Journal:  J Hematol Oncol       Date:  2017-08-14       Impact factor: 17.388

9.  Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia.

Authors:  Henrik Lilljebjörn; Rasmus Henningsson; Axel Hyrenius-Wittsten; Linda Olsson; Christina Orsmark-Pietras; Sofia von Palffy; Maria Askmyr; Marianne Rissler; Martin Schrappe; Gunnar Cario; Anders Castor; Cornelis J H Pronk; Mikael Behrendtz; Felix Mitelman; Bertil Johansson; Kajsa Paulsson; Anna K Andersson; Magnus Fontes; Thoas Fioretos
Journal:  Nat Commun       Date:  2016-06-06       Impact factor: 14.919

10.  RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia.

Authors:  I S Jerchel; A Q Hoogkamer; I M Ariës; E M P Steeghs; J M Boer; N J M Besselink; A Boeree; C van de Ven; H A de Groot-Kruseman; V de Haas; M A Horstmann; G Escherich; C M Zwaan; E Cuppen; M J Koudijs; R Pieters; M L den Boer
Journal:  Leukemia       Date:  2017-10-03       Impact factor: 11.528

View more
  9 in total

Review 1.  Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.

Authors:  Jianfeng Li; Yuting Dai; Liang Wu; Ming Zhang; Wen Ouyang; Jinyan Huang; Saijuan Chen
Journal:  Front Med       Date:  2021-01-05       Impact factor: 4.592

Review 2.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Authors:  Rita Alaggio; Catalina Amador; Ioannis Anagnostopoulos; Ayoma D Attygalle; Iguaracyra Barreto de Oliveira Araujo; Emilio Berti; Govind Bhagat; Anita Maria Borges; Daniel Boyer; Mariarita Calaminici; Amy Chadburn; John K C Chan; Wah Cheuk; Wee-Joo Chng; John K Choi; Shih-Sung Chuang; Sarah E Coupland; Magdalena Czader; Sandeep S Dave; Daphne de Jong; Ming-Qing Du; Kojo S Elenitoba-Johnson; Judith Ferry; Julia Geyer; Dita Gratzinger; Joan Guitart; Sumeet Gujral; Marian Harris; Christine J Harrison; Sylvia Hartmann; Andreas Hochhaus; Patty M Jansen; Kennosuke Karube; Werner Kempf; Joseph Khoury; Hiroshi Kimura; Wolfram Klapper; Alexandra E Kovach; Shaji Kumar; Alexander J Lazar; Stefano Lazzi; Lorenzo Leoncini; Nelson Leung; Vasiliki Leventaki; Xiao-Qiu Li; Megan S Lim; Wei-Ping Liu; Abner Louissaint; Andrea Marcogliese; L Jeffrey Medeiros; Michael Michal; Roberto N Miranda; Christina Mitteldorf; Santiago Montes-Moreno; William Morice; Valentina Nardi; Kikkeri N Naresh; Yasodha Natkunam; Siok-Bian Ng; Ilske Oschlies; German Ott; Marie Parrens; Melissa Pulitzer; S Vincent Rajkumar; Andrew C Rawstron; Karen Rech; Andreas Rosenwald; Jonathan Said; Clémentine Sarkozy; Shahin Sayed; Caner Saygin; Anna Schuh; William Sewell; Reiner Siebert; Aliyah R Sohani; Reuben Tooze; Alexandra Traverse-Glehen; Francisco Vega; Beatrice Vergier; Ashutosh D Wechalekar; Brent Wood; Luc Xerri; Wenbin Xiao
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

Review 3.  Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia.

Authors:  Hiroto Inaba; Ching-Hon Pui
Journal:  J Clin Med       Date:  2021-04-29       Impact factor: 4.241

Review 4.  B-ALL Complexity: Is Targeted Therapy Still A Valuable Approach for Pediatric Patients?

Authors:  Stefano Ratti; Annalisa Lonetti; Matilde Y Follo; Francesca Paganelli; Alberto M Martelli; Francesca Chiarini; Camilla Evangelisti
Journal:  Cancers (Basel)       Date:  2020-11-24       Impact factor: 6.639

Review 5.  NUTM1-Rearranged Neoplasms-A Heterogeneous Group of Primitive Tumors with Expanding Spectrum of Histology and Molecular Alterations-An Updated Review.

Authors:  Wenyi Luo; Todd M Stevens; Phillip Stafford; Markku Miettinen; Zoran Gatalica; Semir Vranic
Journal:  Curr Oncol       Date:  2021-11-07       Impact factor: 3.677

Review 6.  Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.

Authors:  Monika Lejman; Aleksandra Chałupnik; Zuzanna Chilimoniuk; Maciej Dobosz
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

7.  Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy.

Authors:  Sima Jeha; John Choi; Kathryn G Roberts; Deqing Pei; Elaine Coustan-Smith; Hiroto Inaba; Jeffrey E Rubnitz; Raul C Ribeiro; Tanja A Gruber; Susana C Raimondi; Seth E Karol; Chunxu Qu; Samuel W Brady; Zhaohui Gu; Jun J Yang; Cheng Cheng; James R Downing; Williams E Evans; Mary V Relling; Dario Campana; Charles G Mullighan; Ching-Hon Pui
Journal:  Blood Cancer Discov       Date:  2021-07

8.  Brain tumor with an ATXN1-NUTM1 fusion gene expands the histologic spectrum of NUTM1-rearranged neoplasia.

Authors:  Aurore Siegfried; Julien Masliah-Planchon; Franck-Emmanuel Roux; Delphine Larrieu-Ciron; Gaelle Pierron; Yvan Nicaise; Marion Gambart; Isabelle Catalaa; Sarah Péricart; Charlotte Dubucs; Badreddine Mohand-Oumoussa; Franck Tirode; Franck Bourdeaut; Emmanuelle Uro-Coste
Journal:  Acta Neuropathol Commun       Date:  2019-12-30       Impact factor: 7.801

Review 9.  Epigenetic Control of Infant B Cell Precursor Acute Lymphoblastic Leukemia.

Authors:  Oriol de Barrios; Maribel Parra
Journal:  Int J Mol Sci       Date:  2021-03-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.